Haumaier F, Schneider-Fuchs A, Backert S, Sterlacci W, Wöhrl BM, Vieth M (2022)
Publication Type: Journal article
Publication year: 2022
Book Volume: 11
Article Number: 59
Journal Issue: 1
DOI: 10.3390/pathogens11010059
The treatment of infections by the gastric pathogen Helicobacter pylori (H. pylori) has become more difficult due to increased rates of resistances against various antibiotics. Typically, atriple ther-apy, employing a combination of at least two antibiotics and a proton pump inhibitor, is used to cure H. pylori infections. In case of first-line therapy failure, quinolones are commonly applied in a second-line therapy. To prevent second-line treatment failures, we developed an improved method to detect the most common quinolone-resistance mutations located in the quinolone-resistance-determining region (QRDR) of the bacterial gyrA gene. Biopsy material from the gastric mucosa of infected patients was used to identify quinolone-resistant strains before the onset of drug administration. Two different wild-type and six mutant QRDR sequences were included. Melting curve analyses were performed with corresponding gyrA plasmid DNAs using a real-time polymerase chain reaction (RT-PCR) assay. By applying a combination of only two different fluorescent probes, this assay allows wild-type sequences to be unambiguously distinguished from all known mutant QRDR sequences of H. pylori. Next, the T
APA:
Haumaier, F., Schneider-Fuchs, A., Backert, S., Sterlacci, W., Wöhrl, B.M., & Vieth, M. (2022). Rapid Detection of Quinolone Resistance Mutations in gyrA of Helicobacter pylori by Real-Time PCR. Pathogens, 11(1). https://doi.org/10.3390/pathogens11010059
MLA:
Haumaier, Franziska, et al. "Rapid Detection of Quinolone Resistance Mutations in gyrA of Helicobacter pylori by Real-Time PCR." Pathogens 11.1 (2022).
BibTeX: Download